Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000950170-25-018782·Korsana Biosciences, Inc.
Schedule 13G ownership disclosure
CYCLERION THERAPEUTICS INC
Common Stock, no par value · CUSIP: 23255M105
Event date: 2024-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- MFN Partners, LP
Shares: 0 · Class: 0%
- MFN Partners GP, LLC
Shares: 0 · Class: 0%
- MFN Partners Management, LP
Shares: 0 · Class: 0%
- MFN Partners Management, LLC
Shares: 0 · Class: 0%
- Michael F. DeMichele
Shares: 0 · Class: 0%
- Farhad Nanji
Shares: 0 · Class: 0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950170-25-018782
- Form type
- SCHEDULE 13G/A
- Filer
- Korsana Biosciences, Inc.
- CIK
- CIK 1755237
- Filed
- Feb 12, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership